Stocks rose to begin a busy week that will see a flurry of corporate earnings reports, with investors also awaiting further ...
Q3 2025 Earnings Call October 20, 2025 8:30 AM EDTCompany ParticipantsLourenco Goncalves - Chairman, President ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...
Merck’s investment in the Center of Excellence for Pharmaceutical Manufacturing is part of a more than $70 billion investment beginning in 2025 to expand domestic manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results